Mereo Biopharma Group Plc ADR (MREO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,253 | -29,466 | -42,220 | 19,583 | -213,722 |
| Depreciation Amortization | 581 | 566 | 181 | 883 | 2,053 |
| Accounts receivable | N/A | N/A | N/A | -810 | 181 |
| Accounts payable and accrued liabilities | 146 | -1,263 | 617 | -1,727 | -4,560 |
| Other Working Capital | -369 | -1,593 | -2,352 | -2,537 | -4,378 |
| Other Operating Activity | 10,061 | 10,624 | -5,047 | -22,596 | 184,036 |
| Operating Cash Flow | $-32,834 | $-21,132 | $-48,821 | $-7,204 | $-36,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -13 | -736 | -21 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -455 |
| Purchase Sale Intangibles | -699 | -419 | N/A | 155 | 2,338 |
| Other Investing Activity | -699 | -419 | 2,000 | 157 | 2,395 |
| Investing Cash Flow | $-699 | $-419 | $1,987 | $-579 | $1,920 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 56,978 |
| Debt Repayment | N/A | N/A | N/A | N/A | -25,426 |
| Common Stock Issued | 47,000 | 11,605 | N/A | 108,053 | 25,855 |
| Other Financing Activity | -853 | -3,632 | 200 | -1,273 | -12,804 |
| Financing Cash Flow | $46,147 | $7,973 | $200 | $106,779 | $44,602 |
| Exchange Rate Effect | -233 | 2,818 | -12,582 | -1,602 | -987 |
| Beginning Cash Position | 57,421 | 68,182 | 127,398 | 32,272 | 20,990 |
| End Cash Position | 69,802 | 57,421 | 68,182 | 129,666 | 30,134 |
| Net Cash Flow | $12,381 | $-10,761 | $-59,216 | $97,394 | $9,145 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,834 | -21,132 | -48,821 | -7,204 | -36,390 |
| Capital Expenditure | N/A | N/A | -13 | -736 | -21 |
| Free Cash Flow | -32,834 | -21,132 | -48,834 | -7,940 | -36,410 |